aspartic acid has been researched along with Dysmyelopoietic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baerlocher, S; Dirks, J; Dirnhofer, S; Drexler, B; Martinez, M; Passweg, JR; Tsakiris, DA; Tzankov, A | 1 |
| Akiyama, H; Asou, N; Kiyoi, H; Kodera, Y; Kuriyama, K; Miyawaki, S; Motoji, T; Nakano, Y; Naoe, T; Nishimura, M; Ohno, R; Saito, H; Saito, K; Shimazaki, C; Shinagawa, K; Suzuki, R; Takeshita, A; Ueda, R; Yagasaki, F; Yamamoto, Y | 1 |
2 other study(ies) available for aspartic acid and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Biopsy; Bone Marrow; CD56 Antigen; Cell Count; Female; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Young Adult | 2021 |
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.
Topics: Acute Disease; Amino Acid Substitution; Animals; Aspartic Acid; Cell Division; Cell Line; Cell Transformation, Neoplastic; Chlorocebus aethiops; Codon; COS Cells; DNA, Complementary; fms-Like Tyrosine Kinase 3; Hematologic Neoplasms; Humans; Leukemia, Myeloid; Mutagenesis, Site-Directed; Mutation, Missense; Myelodysplastic Syndromes; Point Mutation; Protein Structure, Tertiary; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Tandem Repeat Sequences; Transfection | 2001 |